| Desiree Joanne Gagner-tjellesen, RNCS,APRN,BC | |
|
151 S 4th St, Suite 401, Grand Forks, ND 58201-4715 | |
| (701) 795-3000 | |
| (701) 795-3050 |
| Full Name | Desiree Joanne Gagner-tjellesen |
|---|---|
| Gender | Female |
| Speciality | Certified Clinical Nurse Specialist (cns) |
| Experience | 24 Years |
| Location | 151 S 4th St, Grand Forks, North Dakota |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1518906437 | NPI | - | NPPES |
| 638R1GA | Other | MN | BCBS MN PROVIDER NUMBER |
| 020043 | Other | ND | BCBS ND PROVIDER NUMBER |
| 054519 | Medicaid | ND |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 364S00000X | Clinical Nurse Specialist | R24745 (North Dakota) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Altru Hospital | Grand forks, ND | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Northeast Human Service Center | 1658341441 | 9 |
News Archive
The TURis plasma vaporization electrode does not cut off tissue with a loop, but energetically vaporizes the tissue with a small button electrode. With the help of the latest plasma technology, cells can be removed by merely gliding the electrode over the prostate tissue.
VIVUS, Inc. today announced that the company filed a Marketing Authorization Application (MAA) with the European Medicines Agency (EMA) for QNEXA® (phentermine/topiramate) Controlled Release Capsules in the European Union (EU). The proposed indication in the EU is for the treatment of obesity, including weight loss and maintenance of weight loss, and should be used in conjunction with a mildly hypocaloric diet.
Encapsulating human stem-cell-derived beta cells in microcapsules made with a protein that repels key immune cells restored glucose metabolism in diabetic mice and protected the cells from immune system attack, preventing the buildup of inflammatory fibrotic tissue that has plagued previous trials of encapsulated beta cells.
New research launched today, 1st September 2014, has concluded that there are seven key issues that need to be addressed to ensure the future success of doctor revalidation, the most profound revision in medical regulation since the Medical Act of 1858.
An enzyme previously associated with preventing the dementia of Alzheimer's disease now appears to play an even bigger role in safeguarding against the disease, bringing the promise of new targets for drug therapies.
› Verified 9 days ago
| Entity Name | Northeast Human Service Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1366496341 PECOS PAC ID: 1658341441 Enrollment ID: O20040729000033 |
News Archive
The TURis plasma vaporization electrode does not cut off tissue with a loop, but energetically vaporizes the tissue with a small button electrode. With the help of the latest plasma technology, cells can be removed by merely gliding the electrode over the prostate tissue.
VIVUS, Inc. today announced that the company filed a Marketing Authorization Application (MAA) with the European Medicines Agency (EMA) for QNEXA® (phentermine/topiramate) Controlled Release Capsules in the European Union (EU). The proposed indication in the EU is for the treatment of obesity, including weight loss and maintenance of weight loss, and should be used in conjunction with a mildly hypocaloric diet.
Encapsulating human stem-cell-derived beta cells in microcapsules made with a protein that repels key immune cells restored glucose metabolism in diabetic mice and protected the cells from immune system attack, preventing the buildup of inflammatory fibrotic tissue that has plagued previous trials of encapsulated beta cells.
New research launched today, 1st September 2014, has concluded that there are seven key issues that need to be addressed to ensure the future success of doctor revalidation, the most profound revision in medical regulation since the Medical Act of 1858.
An enzyme previously associated with preventing the dementia of Alzheimer's disease now appears to play an even bigger role in safeguarding against the disease, bringing the promise of new targets for drug therapies.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Desiree Joanne Gagner-tjellesen, RNCS,APRN,BC 151 S 4th St, Suite 401, Grand Forks, ND 58201-4715 Ph: (701) 795-3000 | Desiree Joanne Gagner-tjellesen, RNCS,APRN,BC 151 S 4th St, Suite 401, Grand Forks, ND 58201-4715 Ph: (701) 795-3000 |
News Archive
The TURis plasma vaporization electrode does not cut off tissue with a loop, but energetically vaporizes the tissue with a small button electrode. With the help of the latest plasma technology, cells can be removed by merely gliding the electrode over the prostate tissue.
VIVUS, Inc. today announced that the company filed a Marketing Authorization Application (MAA) with the European Medicines Agency (EMA) for QNEXA® (phentermine/topiramate) Controlled Release Capsules in the European Union (EU). The proposed indication in the EU is for the treatment of obesity, including weight loss and maintenance of weight loss, and should be used in conjunction with a mildly hypocaloric diet.
Encapsulating human stem-cell-derived beta cells in microcapsules made with a protein that repels key immune cells restored glucose metabolism in diabetic mice and protected the cells from immune system attack, preventing the buildup of inflammatory fibrotic tissue that has plagued previous trials of encapsulated beta cells.
New research launched today, 1st September 2014, has concluded that there are seven key issues that need to be addressed to ensure the future success of doctor revalidation, the most profound revision in medical regulation since the Medical Act of 1858.
An enzyme previously associated with preventing the dementia of Alzheimer's disease now appears to play an even bigger role in safeguarding against the disease, bringing the promise of new targets for drug therapies.
› Verified 9 days ago
Ms. Mary Louise Riske, RN, CNS Clinical Nurse Specialist Medicare: Not Enrolled in Medicare Practice Location: 501 Columbia Rd., Stop 9037, Grand Forks, ND 58202 Phone: 701-777-4243 | |
Suzanne Kay Obrien, ANP Clinical Nurse Specialist Medicare: Not Enrolled in Medicare Practice Location: 1000 S Columbia Rd, Grand Forks, ND 58201 Phone: 701-780-5000 Fax: 701-780-1942 | |
Kris Elaine Stellon, APRN-CNS Clinical Nurse Specialist Medicare: Not Enrolled in Medicare Practice Location: 1000 S Columbia Rd, Grand Forks, ND 58201 Phone: 701-780-5000 Fax: 701-780-1942 | |
Jeanine Louise Senti, APRN, CNS Clinical Nurse Specialist Medicare: Not Enrolled in Medicare Practice Location: 1200 S Columbia Rd, Grand Forks, ND 58201 Phone: 701-780-5000 | |
Nancy Joyner, APRN BC Clinical Nurse Specialist Medicare: Not Enrolled in Medicare Practice Location: 702 Belmont Rd, Grand Forks, ND 58201 Phone: 701-746-4728 | |
Cheryl Ann Stauffenecker, CNS,MS, RNBC Clinical Nurse Specialist Medicare: Not Enrolled in Medicare Practice Location: 1000 S Columbia Rd, Grand Forks, ND 58201 Phone: 701-780-5000 Fax: 701-780-1942 |